Skip to main content
. 2009 Feb 17;100(4):737–746. doi: 10.1111/j.1349-7006.2009.01083.x

Figure 7.

Figure 7

Dehydroxymethylepoxyquinomicin (DHMEQ) rescued primary effusion lymphoma (PEL) xenografted mice. Mice at 5 weeks old were injected with 4 × 106 TY 1 cells intraperitoneally. DHMEQ (8 mg/kg) in 0.5% CMC was administered three times a week intraperitoneally for 1 month. Dimethyl sulfoxide in 0.5% CMC was administered to the control group. (A) Gross appearances of the mice. (B) A graph showing weights of mice with mean values. (C) Survival curves of mice with or without DHMEQ treatment.